However, in cancer, the CD28 homologue CTLA-4 is translocated from intracellular storage to the plasma membrane of T cells, competitively binds to B7 ligands on antigen presenting cells (APCs) with higher affinity, thereby preventing CD28-mediated T cell activation. This evidence concerns the gene CD28 and cancer.